Skip to main content
Timmy Lee, MD, Nephrology, Birmingham, AL

TimmyLeeMD

Nephrology Birmingham, AL

Chronic Renal Failure & Dialysis, Hypertension, Interventional Nephrology

Professor of Medicine, University of Alabama at Birmingham; Section Chief, Nephrology, Birmingham Veterans Affairs Medical Center

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

  • Office

    2000 6th Ave S
    Birmingham, AL 35233
    Phone+1 205-934-9999
    Fax+1 205-933-4497

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Nephrology, 2004 - 2007
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Internal Medicine, 2001 - 2004
  • LSU School of Medicine in Shreveport
    LSU School of Medicine in ShreveportClass of 2001
  • Washington University in St. Louis
    Washington University in St. LouisB.A., Chemistry, Cum Laude, 1993 - 1997

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2003 - 2024
  • OH State Medical License
    OH State Medical License 2007 - 2014
  • IN State Medical License
    IN State Medical License 2007 - 2013
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Carl W. Gottschalk Scholar Grant American Society of Nephrology, 2014
  • Satellite Healthcare Norman S. Coplon Extramural Research Grant 2014
  • Fellow National Kidney Foundation (FNKF), 2012
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Pathogenic Role of Early Macrophage Infiltration in a Pig Model of Arteriovenous Fistula (AVF) Stenosis  
    Campos B, Wang Y, Mistry M, Woodle B, Cornea V, Lee T, and Roy-Chaudhury P, J Vasc Access, 1/1/2014
  • Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: determining the timing and expectation of therapy  
    Boye, S.E., Huang, W.C., Roman, A.J., Sumaroka, A., Boye, S.L., Ryals, R.C., Olivares, M.B., Ruan, Q., Tucker, B.A., Stone, E.M., Swaroop, A., Cideciyan, A.V., Hauswir..., PLoS One, 1/1/2014
  • Canine retina has a primate fovea-like bouquet of cone photoreceptors which is affected by inherited macular degenerations  
    Beltran, W.A., Cideciyan, A.V., Guziewicz, K.E., Iwabe, S., Swider, M., Scott, E.M., Savina, S.V., Ruthel, G., Stefano, F., Zhang, L., Zorger, R., Sumaroka, A., Jacobs..., PLoS One, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Are Vascular Access Outcomes in the Fistula First Era Affected by the Surgeon?
    Lee T and Allon M, Am J Kidney Dis
  • Improvement in biomarkers after intrathecal iduronidase for children with MPS IH.
    Lund TC, Miller W, Polgreen L, Baso L, Raymond G, Tolar J, Orchard P, Mol Genet Metabol, 1/1/2014
  • The outpatient management of ketosis-prone diabetes at Bellevue Hospital.
    Ghosh AK, Osman J, Levy NK, Journal of General Internal Medicine, 1/1/2014
  • Join now to see all

Lectures

  • Keeping the Bugs Away: Preventing, Diagnosing, and Treating Common Infections in the Dialysis Unit 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/8/2019
  • Respiratory Illnesses. 
    1/1/2014
  • The Efficient Clinical Session 
    1/18/2013
  • Join now to see all

Press Mentions

  • Humacyte to Host Virtual KOL Event on the Use of Acellular Tissue Engineered Vessel (ATEV™) for AV Access in Hemodialysis on October 31, 2024
    Humacyte to Host Virtual KOL Event on the Use of Acellular Tissue Engineered Vessel (ATEV™) for AV Access in Hemodialysis on October 31, 2024October 23rd, 2024
  • Proteon Therapeutics Announces Second Quarter 2018 Financial Results
    Proteon Therapeutics Announces Second Quarter 2018 Financial ResultsAugust 7th, 2018
  • Care Could Improve for Dialysis Patients with Development of Bionanomatrix Gel with $2 Million Grant
    Care Could Improve for Dialysis Patients with Development of Bionanomatrix Gel with $2 Million GrantOctober 5th, 2017
  • Join now to see all

Professional Memberships